Human CD11a/LFA-1a-SPRD Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Human CD11a/LFA-1a-SPRD antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Human CD11a/LFA-1a-SPRD |
| Clone | [38] |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2a |
| Format | unconjugated |
| Size | 100 tests |
| Concentration | n/a |
| Applications | Flow Cytometry, Studies in cell adhesion and cytotoxicity, Immunohistochemisty (Frozen sections), Immunoprecipitation, Blocking studies |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: Human CD11a (LFA-1alpha). CD11a, also known as leukocyte function-associated antigen-1 (LFA-1alpha), represents the 180 kDa integrin alphaL subunit which combines with the CD18 beta2 integrin subunit to form the alphaLbeta2 integrin heterodimer. It is expressed on lymphocytes, granulocytes, monocytes, and macrophages and is upregulated on activated T cells. CD11a/LFA-1alpha mediates adhesion of lymphocytes to vascular endothelium and is involved in costimulation.1-5. |
| Immunogen | n/a |
| Other Names | n/a |
| Gene, Accession # | n/a |
| Catalog # | MBS670258 |
| Price | $305 |
| Order / More Info | Human CD11a/LFA-1a-SPRD Antibody from MYBIOSOURCE INC. |
| Product Specific References | 1. Barclay, A.N., M.H. Brown, S.K.A. Law, A.J. McKnight, M.G. Tomlinson, and P.A. van der Merwe, eds. 1997. The Leukocyte Antigens Facts Book, 2nd Edition, CD11a Section, Academic Press, New York, p. 156.2. Dransfield, I., and N. Hogg. 1989. EMBO J. 12:3759.3. Springer, T.A. 1990. Nature 346:425.4. Springer, T.A. 1994. Cell 76:301.5. Lub, M., Y. van Kooyk, and C.G. Figdor. 1995. Immunol. Today 16:479. |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies